Results of transurethral resection and intravesical doxorubicin prophylaxis in patients with T1G3 bladder cancer.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Urology

• Publication date

  1994-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0090-4295(94)80086-3PMID 8073548
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Natural history of superficial bladder cancer. Prognostic features and long-term disease course.

  1992cited by this paper
• Recurrent or aggressive bladder cancer. Indications for adjuvant intravesical therapy.

  1992cited by this paper
• pT1 bladder cancer.

  1991cited by this paper
• Progression of stage T1 bladder tumors after intravesical bacillus Calmette-Guerin.

  1991cited by this paper
• Comparison of different schedules of cytostatic intravesical instillations in patients with superficial bladder carcinoma: final evaluation of a prospective multicenter study with 419 patients.

  1990cited by this paper
• Bacillus Calmette-Guerin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder cancer.

  1990cited by this paper
• Prognostic factors for recurrence and followup policies in the treatment of superficial bladder cancer: report from the British Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party).

  1989cited by this paper
• Stage T1, grade 3 transitional cell carcinoma of the bladder: an unfavorable tumor?

  1987cited by this paper
• Cancer Clinical Trials: Methods and Practice.

  1985cited by this paper
• Urothelial dysplasia concomitant with bladder tumours as a determinant factor for future new occurrences.

  1983cited by this paper
• Superficial bladder cancer: progression and recurrence.

  1983cited by this paper
• Bladder cancer: factors affecting survival.

  1983cited by this paper
• Prognostic factors in superficial bladder tumors. A study of the European Organization for Research on Treatment of Cancer: Genitourinary Tract Cancer Cooperative Group.

  1983cited by this paper
• Prognostic parameters in superficial bladder cancer: an analysis of 315 cases.

  1982cited by this paper
• DNA pattern, histological grade and multiplicity related to recurrence rate in superficial bladder tumours.

  1982cited by this paper
• The correlation of T1 bladder tumour history with prognosis and follow-up requirements.

  1981cited by this paper
• Factors influencing the recurrence rate of bladder cancer.

  1980cited by this paper
• The natural history of papillary transitional cell carcinoma of the bladder and its treatment in an unselected population on the basis of histologic grading.

  1978cited by this paper
• Ureteric diversion using a conduit: a simplified technique.

  1966cited by this paper

• Sex-specific differences in recurrence and progression following cytostatic intravesical chemotherapy for non-muscle invasive urothelial bladder cancer (NMIBC)

  2025cites this paper
• Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial.

  2010cites this paper
• Is T1G3 bladder cancer having a definite muscle layer in TUR specimens a highly progressive disease?

  2010cites this paper
• Tumor multiplicity is an independent prognostic factor of non-muscle-invasive high-grade (T1G3) bladder cancer.

  2010cites this paper
• Apoptosis and fas system are significantly involved in the process of liver cirrhosis converting into hepatocellular carcinoma

  2008cites this paper
• Novel gelatin-adriamycin sustained drug release system for intravesical therapy of bladder cancer

  2008cites this paper
• Management of stage T1 tumors of the bladder: International Consensus Panel.

  2005cites this paper
• TUR and adjuvant intravesical chemotherapy in T1G3 bladder tumors: recurrence, progression and survival in 137 selected patients followed up to 20 years.

  2004cites this paper
• Les tumeurs superficielles de vessie pT1G3 : à propos de 24 cas

  2003cites this paper
• [Superficial pT1G3 bladder tumor: 24 case reports].

  2003cites this paper
• Prognostic significance of platelet‐derived endothelial cell growth factor/thymidine phosphorylase expression in stage pT1 G3 bladder cancer

  2001cites this paper
• Blasencarcinome und Carcinome des Übergangsepithels

  2001cites this paper
• Novel gelatin-adriamycin sustained drug release system for intravesical therapy of bladder cancer.

  2001cites this paper
• Transurethral Resection and Sequential Chemo–Immunoprophylaxis in Primary T1G3 Bladder Cancer

  2000cites this paper
• The 3-month clinical response to intravesical therapy as a predictive factor for progression in patients with high risk superficial bladder cancer.

  2000cites this paper
• pT1 Urothelial Carcinoma of the Bladder: Criteria for Diagnosis, Pitfalls, and Clinical Implications

  2000cites this paper
• Recurrence and progression of stage T1, grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with bacillus Calmette-Guerin.

  2000cites this paper
• T1 GIII Bladder Cancer

  1999cites this paper
• Potential value of urinary intercellular adhesion molecule-1 determination in patients with bladder cancer.

  1998cites this paper
• Relationship among cystectomy, microvessel density and prognosis in stage T1 transitional cell carcinoma of the bladder.

  1998cites this paper
• [Clinical evaluation of grade 3 superficial bladder cancer].

  1996cites this paper
• Results of conservative treatment (transurethral resection plus adjuvant intravesical chemotherapy) in patients with primary T1, G3 transitional cell carcinoma of the bladder.

  1996cites this paper
• Bacillus Calmette-Guerin in the treatment of stage T1 grade 3 transitional cell carcinoma of the bladder: long-term results.

  1995cites this paper
• BACILLUS CALMETTE-GUERIN IN THE TREATMENT OF STAGE Tl GRADE 3 TRANSITIONAL CELL CARCINOMA OF THE BLADDER: LONG-TERM RESULTS

  1995cites this paper